Charles Dadswell
General Counsel bei ILLUMINA, INC.
Vermögen: 3 Mio $ am 30.04.2024
Aktive Positionen von Charles Dadswell
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ILLUMINA, INC. | General Counsel | 22.04.2013 | - |
Unternehmenssekretär | - | - | |
Vorstandsvorsitzender | 11.06.2023 | 25.09.2023 | |
Compliance Officer | - | - |
Karriereverlauf von Charles Dadswell
Ehemalige bekannte Positionen von Charles Dadswell
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
bioMérieux, Inc.
bioMérieux, Inc. Medical SpecialtiesHealth Technology bioMérieux, Inc. develops in-vitro diagnostics solutions. It offers microbiological testing solutions for medical and industrial applications. The company was founded on December 31, 1986 and is headquartered in Durham, NC. | General Counsel | 01.01.2011 | 01.04.2013 |
BIODELIVERY SCIENCES INTERNATIONAL, INC. | General Counsel | - | 01.01.2010 |
Glaxo Wellcome, Inc. | Corporate Officer/Principal | - | - |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Corporate Officer/Principal | - | - |
Ausbildung von Charles Dadswell
Ferris State University (Michigan) | Undergraduate Degree |
The Thomas M. Cooley Law School | Graduate Degree |
George Washington University Law School | Graduate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Kanada | 2 |
Operativ
General Counsel | 3 |
Corporate Officer/Principal | 2 |
Graduate Degree | 2 |
Sektoral
Health Technology | 6 |
Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ILLUMINA, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
BioDelivery Sciences International, Inc.
BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. | Health Technology |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Health Technology |
Glaxo Wellcome, Inc. | Health Technology |
bioMérieux, Inc.
bioMérieux, Inc. Medical SpecialtiesHealth Technology bioMérieux, Inc. develops in-vitro diagnostics solutions. It offers microbiological testing solutions for medical and industrial applications. The company was founded on December 31, 1986 and is headquartered in Durham, NC. | Health Technology |
- Börse
- Insiders
- Charles Dadswell
- Erfahrung